Journal
CLINICAL AND EXPERIMENTAL IMMUNOLOGY
Volume 180, Issue 2, Pages 178-188Publisher
WILEY
DOI: 10.1111/cei.12483
Keywords
AAV; ANCA; CD5; interleukin-10; regulatory B cells
Categories
Funding
- NIH/NIDDK [5P01DK058335-14, 3P01DK058335-14S1]
- Vasculitis Foundation
- NCI Center Core Support Grant [P30CA06086]
Ask authors/readers for more resources
Pathogenesis of anti-neutrophil cytoplasmic autoantibody (ANCA)-associated vasculitis is B cell-dependent, although how particular B cell subsets modulate immunopathogenesis remains unknown. Although their phenotype remains controversial, regulatory B cells (B-regs), play a role in immunological tolerance via interleukin (IL)-10. Putative CD19(+)CD24(hi)CD38(hi) and CD19(+)CD24(hi)CD27(+) B-regs were evaluated in addition to their CD5(+) subsets in 69 patients with ANCA-associated vasculitis (AAV). B cell IL-10 was verified by flow cytometry following culture with CD40 ligand and cytosine-phosphate-guanosine (CpG) DNA. Patients with active disease had decreased levels of CD5(+)CD24(hi)CD38(hi) B cells and IL-10(+) B cells compared to patients in remission and healthy controls (HCs). As IL-10(+) and CD5(+)CD24(hi)CD38(hi) B cells normalized in remission within an individual, ANCA titres decreased. The CD5(+) subset of CD24(hi)CD38(hi) B cells decreases in active disease and rebounds during remission similarly to IL-10-producing B cells. Moreover, CD5(+) B cells are enriched in the ability to produce IL-10 compared to CD5(neg) B cells. Together these results suggest that CD5 may identify functional IL-10-producing B-regs. The malfunction of B-regs during active disease due to reduced IL-10 expression may thus permit ANCA production.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available